[go: up one dir, main page]

NO20005385L - Orale legemiddelpreparater med reproduserbar virkestoffrigivning av gatifloxacin eller dens farmasöytisk anvendelige salter eller hydrater - Google Patents

Orale legemiddelpreparater med reproduserbar virkestoffrigivning av gatifloxacin eller dens farmasöytisk anvendelige salter eller hydrater

Info

Publication number
NO20005385L
NO20005385L NO20005385A NO20005385A NO20005385L NO 20005385 L NO20005385 L NO 20005385L NO 20005385 A NO20005385 A NO 20005385A NO 20005385 A NO20005385 A NO 20005385A NO 20005385 L NO20005385 L NO 20005385L
Authority
NO
Norway
Prior art keywords
gatifloxacin
hydrates
pharmaceutically acceptable
acceptable salts
medicinal products
Prior art date
Application number
NO20005385A
Other languages
English (en)
Other versions
NO20005385D0 (no
Inventor
Johannes Heinich Bartholomaeus
Juergen Betzing
Original Assignee
Gruenenthal Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Gruenenthal Gmbh filed Critical Gruenenthal Gmbh
Publication of NO20005385D0 publication Critical patent/NO20005385D0/no
Publication of NO20005385L publication Critical patent/NO20005385L/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A61K31/4709—Non-condensed quinolines and containing further heterocyclic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
NO20005385A 1998-05-09 2000-10-26 Orale legemiddelpreparater med reproduserbar virkestoffrigivning av gatifloxacin eller dens farmasöytisk anvendelige salter eller hydrater NO20005385L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE19820801A DE19820801A1 (de) 1998-05-09 1998-05-09 Orale Arzneiformen mit reproduzierbarer Wirkstofffreisetzung von Gatifloxacin oder pharmazeutisch verwendbaren Salzen oder Hydraten
PCT/EP1999/002893 WO1999058129A1 (de) 1998-05-09 1999-04-29 Orale arzneiformen mit reproduzierbarer wirkstofffreisetzung von gatifloxacin oder pharmazeutisch verwendbaren salzen oder hydraten

Publications (2)

Publication Number Publication Date
NO20005385D0 NO20005385D0 (no) 2000-10-26
NO20005385L true NO20005385L (no) 2000-10-26

Family

ID=7867223

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20005385A NO20005385L (no) 1998-05-09 2000-10-26 Orale legemiddelpreparater med reproduserbar virkestoffrigivning av gatifloxacin eller dens farmasöytisk anvendelige salter eller hydrater

Country Status (27)

Country Link
US (1) US6291462B1 (no)
EP (1) EP1077703B1 (no)
JP (1) JP2002514600A (no)
KR (1) KR100587210B1 (no)
CN (1) CN1198615C (no)
AR (1) AR019279A1 (no)
AT (1) ATE235242T1 (no)
AU (1) AU753482B2 (no)
BR (1) BR9910350A (no)
CA (1) CA2325636A1 (no)
CO (1) CO5050341A1 (no)
DE (2) DE19820801A1 (no)
DK (1) DK1077703T3 (no)
ES (1) ES2195573T3 (no)
HU (1) HUP0101597A3 (no)
IL (1) IL139512A0 (no)
MY (1) MY118569A (no)
NO (1) NO20005385L (no)
NZ (1) NZ507968A (no)
PE (1) PE20000480A1 (no)
PL (1) PL343936A1 (no)
PT (1) PT1077703E (no)
RU (1) RU2226394C2 (no)
SK (1) SK16772000A3 (no)
UA (1) UA60364C2 (no)
WO (1) WO1999058129A1 (no)
ZA (1) ZA200006440B (no)

Families Citing this family (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE60017180T2 (de) 1999-10-08 2005-12-08 Affinium Pharmaceuticals, Inc., Toronto Fab i inhibitoren
US6413969B1 (en) * 2000-09-13 2002-07-02 Bristol-Myers Squibb Company Gatifloxacin pentahydrate
JP4387804B2 (ja) * 2001-04-06 2009-12-24 アフィニアム・ファーマシューティカルズ・インコーポレイテッド ＦａｂＩ阻害剤
US6589955B2 (en) * 2001-06-20 2003-07-08 Bristol-Myers Squibb Company Pediatric formulation of gatifloxacin
SI1575951T1 (sl) * 2002-12-06 2014-10-30 Debiopharm International Sa Forum "Apres-Demain" Heterociklične spojine, postopki za njihovo izdelavo in njihova uporaba v terapiji
DE602004016831D1 (de) 2003-03-17 2008-11-13 Affinium Pharm Inc Pharmazeutische zusammensetzungen inhibitoren von fab i und weitere antibiotika enthaltend
US20050031683A1 (en) * 2003-08-04 2005-02-10 Ashish Kapoor Solid pharmaceutical composition
WO2005021000A1 (en) * 2003-08-28 2005-03-10 Ranbaxy Laboratories Limited Solid oral dosage forms of gatifloxacin
AR048431A1 (es) * 2004-03-17 2006-04-26 Novartis Ag Formulaciones galenicas de compuestos organicos
EP2848614A3 (en) * 2004-06-04 2015-07-29 Debiopharm International SA Acrylamide derivatives as antibiotic agents
US20060247255A1 (en) * 2005-05-02 2006-11-02 Patel Satishkumar A Method for preparing a stable gatifloxacin composition
ATE493105T1 (de) * 2005-08-02 2011-01-15 Baxter Int Mehrkammerbehälter
US20090156578A1 (en) * 2005-12-05 2009-06-18 PAULS Henry 3-Heterocyclylacrylamide Compounds as Fab I Inhibitors and Antibacterial Agents
EP2687533B1 (en) 2006-07-20 2017-07-19 Debiopharm International SA Acrylamide derivatives as FAB I inhibitors
CN100415212C (zh) * 2006-07-21 2008-09-03 哈药集团制药总厂 一种含乳酸卡德沙星的口服制剂
CA2563690C (en) * 2006-10-12 2014-10-07 Pharmascience Inc. Pharmaceutical compositions comprising intra- and extra- granular fractions
WO2008098374A1 (en) 2007-02-16 2008-08-21 Affinium Pharmaceuticals, Inc. Salts, prodrugs and polymorphs of fab i inhibitors
LT2861608T (lt) 2012-06-19 2019-07-10 Debiopharm International Sa (e)-n-metil-n-((3-metilbenzofuran-2-il)metil)-3-(7-okso-5,6,7,8-tetrahidro-1,8-nafthidrin-3-il)akrilamido provaisto dariniai
AU2017223037B2 (en) 2016-02-26 2022-04-14 Debiopharm International S.A. Medicament for treatment of diabetic foot infections
CN116327781A (zh) 2019-02-14 2023-06-27 德彪药业国际股份公司 阿法比星制剂及其制备方法
MX2021015513A (es) 2019-06-14 2022-04-20 Debiopharm Int Sa Medicamento y uso del mismo para tratar infecciones bacterianas que involucran una biopelicula.

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH089597B2 (ja) * 1986-01-21 1996-01-31 杏林製薬株式会社 選択毒性に優れた８‐アルコキシキノロンカルボン酸およびその塩並びにその製造方法
ES2061623T3 (es) * 1987-03-02 1994-12-16 Brocades Pharma Bv Procedimiento para la obtencion de una composicion farmaceutica y un granulado farmaceutico.
ES2089498T3 (es) * 1991-01-30 1996-10-01 Wellcome Found Comprimidos dispersables en agua.
GB9109862D0 (en) * 1991-05-08 1991-07-03 Beecham Lab Sa Pharmaceutical formulations
JP2647338B2 (ja) * 1993-02-10 1997-08-27 武田薬品工業株式会社 素錠およびその製造方法
US5436253A (en) * 1993-09-08 1995-07-25 Daiichi Pharmaceutical Co., Ltd. Pyridonecarboxylic acid derivatives and mycotic infections
CN1093758C (zh) * 1994-12-19 2002-11-06 第一制药株式会社 缓释粒状制剂及其制备方法
JP3449658B2 (ja) * 1994-12-21 2003-09-22 杏林製薬株式会社 安定性に優れた８−アルコキシキノロンカルボン酸水和物並びにその製造方法
US5945124A (en) * 1995-07-05 1999-08-31 Byk Gulden Chemische Fabrik Gmbh Oral pharmaceutical composition with delayed release of active ingredient for pantoprazole
US5837292A (en) * 1996-07-03 1998-11-17 Yamanouchi Europe B.V. Granulate for the preparation of fast-disintegrating and fast-dissolving compositions containing a high amount of drug
CA2311734C (en) * 2000-04-12 2011-03-08 Bristol-Myers Squibb Company Flash-melt oral dosage formulation

Also Published As

Publication number Publication date
ES2195573T3 (es) 2003-12-01
EP1077703B1 (de) 2003-03-26
JP2002514600A (ja) 2002-05-21
CN1300216A (zh) 2001-06-20
NO20005385D0 (no) 2000-10-26
IL139512A0 (en) 2001-11-25
ATE235242T1 (de) 2003-04-15
DE59904737D1 (de) 2003-04-30
MY118569A (en) 2004-12-31
KR100587210B1 (ko) 2006-06-08
RU2226394C2 (ru) 2004-04-10
DE19820801A1 (de) 1999-11-25
DK1077703T3 (da) 2003-06-23
KR20010043408A (ko) 2001-05-25
AU753482B2 (en) 2002-10-17
PE20000480A1 (es) 2000-05-20
PT1077703E (pt) 2003-08-29
BR9910350A (pt) 2001-09-25
ZA200006440B (en) 2002-02-08
CN1198615C (zh) 2005-04-27
HUP0101597A3 (en) 2003-01-28
AU4035299A (en) 1999-11-29
SK16772000A3 (sk) 2001-05-10
WO1999058129A1 (de) 1999-11-18
CO5050341A1 (es) 2001-06-27
PL343936A1 (en) 2001-09-10
EP1077703A1 (de) 2001-02-28
CA2325636A1 (en) 1999-11-18
UA60364C2 (uk) 2003-10-15
NZ507968A (en) 2002-12-20
US6291462B1 (en) 2001-09-18
HK1033281A1 (en) 2001-08-24
AR019279A1 (es) 2002-02-13
HUP0101597A2 (hu) 2001-11-28

Similar Documents

Publication Publication Date Title
NO20005385D0 (no) Orale legemiddelpreparater med reproduserbar virkestoffrigivning av gatifloxacin eller dens farmasøytisk anvendelige salter eller hydrater
HRPK20040323B3 (en) Oral dosage form for propiverine or its pharmaceutically acceptable salts with an extended release of the active ingredient
AU2002346973A1 (en) Oral Dosage Form for Propiverine or its Pharmaceutically Acceptable Salts with an Extended Release of the Active Ingredient
NO992097D0 (no) Polymerholdig preparat med kontrollert avgivelse av aktiv forbindelse
NO20020976L (no) Retarderte, orale, farmasöytiske administreringsformer
EE200100495A (et) Sahhariidijääkidega asendatud 1,4-bensotiasepiin-1,1-dioksiidi derivaadid, meetod nende valmistamiseks, ühendite kasutamine ning neid sisaldav ravim
HUP0200895A3 (en) Benzimidazole derivatives of alpha-substituted carboxylic acids, pharmaceutical compositions containing them and their use
NO20004823L (no) Nye galeniske formuleringer av meloksicam for oral administrering
LTPA2014005I1 (lt) Chinazolidino dariniai, minėtus junginius turintys vaistai, jų panaudojimas ir jų gavimo būdas
EE04578B1 (et) Farmatseutiline kompositsioon N-piperidino-3-pürasoolkarboksamiidi derivaadi, tema soolade ja nendesolvaatide suu kaudu manustamiseks
NO20002977D0 (no) Terapeutisk formulering for administrasjon av tolterodin med kontrollert frigivelse
AU2001230892A1 (en) Orally administered pharmaceutical formulations of benzimidazole derivatives andthe method of preparing the same
NO20012248L (no) Farmasöytisk preparat av moksifloksacin
EE200000659A (et) 4-(3,5-bis-trifluorometüülbensüülamino)-2-etüül-6-trifluorometüül-3,4-dihüdro-2H-kin oliin-1-karboksüülhappe etüülestrid või nende soolad ja valmistamise meetodid
NO953367L (no) Anvendelse av substituerte 4-fenyl-6-amino-nikotinsyre-derivater som legemidler
EG24397A (en) Salts of keto acids and amine derivatives and their use for the preparation of medicaments
NO20012541D0 (no) Anvendelse av fosfonomaursyrederivater for behandling av infeksjoner
NO20013851D0 (no) Salter med opprettholdt frigivning av farmasoytisk ative peptider samt fremstilling derav
AU5241200A (en) Retard formulation of amoxicillin for oral administration
DK1071397T3 (da) Levosimendan-holdige lægemidler til oral indgivelse med kontrolleret frisætning af det aktive middel
NO20006073D0 (no) Fremgangsmåte for fremstilling av krystallinske salter av amoxycillin
NO20012540D0 (no) Anvendelse av fosfonomaursyrederivater for behandling av infeksjoner
SI1077703T1 (en) Oral medicinal preparations with reproducible release of the active ingredient gatifloxacin or its pharmaceutically suitable salts or hydrates
EE04612B1 (et) 5-kloro-2-metoksü-N-[2-(4-metoksü-3-metüülaminotiokarbonüülaminosulfonüülfenüül)etüül]bensamiidi naatriumsoola kristallvormid, meetod nende valmistamiseks ning neid sisaldav farmatseutiline preparaat
NO20013453D0 (no) Fremgangsmåte for fremstilling av salter av cyanobenzylaminer

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application